A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Yasuhiro Takeshima, Eugenio Mercuri et al.|Neuromuscular Disorders|2017Cited by 128
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patientsElena Mazzone, Eugenio Mercuri, A. Febrer et al.|Neuromuscular Disorders|2014Cited by 64
Six minute walk test in type III spinal muscular atrophy: A 12 month longitudinal studyElena Mazzone, Eugenio Mercuri, F. Bianco et al.|Neuromuscular Disorders|2013Cited by 60
Ultrasound assessment of diaphragmatic function in type 1 spinal muscular atrophyDanilo Buonsenso, Marika Pane, Beatrice Berti et al.|Pediatric Pulmonology|2020Cited by 22
Revised North Star ambulatory assessment for young boys with Duchenne muscular dystrophyEugenio Mercuri, Marika Pane, Giorgia Coratti et al.|Neuromuscular Disorders|2016Cited by 3